Skip to main content

Yutopar Side Effects

Generic name: ritodrine

Medically reviewed by Last updated on Oct 1, 2023.

Note: This document contains side effect information about ritodrine. Some dosage forms listed on this page may not apply to the brand name Yutopar.

Applies to ritodrine: intravenous solution.


Cardiovascular side effects have included tachycardia or other cardiac arrhythmias (80% to 100%), diastolic blood pressure reduction resulting in dizziness and lightheadedness (80% to 100%), and chest pain or tightness (15%). Myocardial ischemia and palpitations have also been reported.[Ref]

Nervous system

Nervous system side effects have included tremor and headache (10% to 50%). Nervousness, jitteriness, and restlessness have also been reported.[Ref]


Dermatologic side effects have included erythema and rash.[Ref]


Gastrointestinal side effects have included nausea and vomiting.[Ref]


Hematologic side effects have included leukopenia and agranulocytosis. Associated with long-term (2 to 3 weeks) use, these effects were reversible upon discontinuation.[Ref]


Hepatic side effects have included hepatitis or impaired hepatic function.[Ref]


Symptoms associated with hyperglycemia included: blurred vision; drowsiness; dry mouth; flushed, dry skin; fruit-like breath odor; increased frequency and volume of urination; ketones in urine; loss of appetite; somnolence; stomachache; nausea, or vomiting; tiredness; and unusual thirst.[Ref]

Metabolic side effects have included transient maternal hyperglycemia and ketoacidosis.[Ref]


Respiratory side effects have included pulmonary edema (shortness of breath).[Ref]


Psychiatric side effects have included anxiety and emotional upset.[Ref]


1. Product Information. Yutopar (ritodrine). Astra-Zeneca Pharmaceuticals. 2001.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.